ClinicalTrials.Veeva

Menu

Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules (BIRADS)

Zhejiang University logo

Zhejiang University

Status

Unknown

Conditions

Breast Cancer
Pathology
Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT04929132
SAHZhejiangU 123

Details and patient eligibility

About

The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS).

Full description

The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed to evaluated the added value in BI-RADS 4A nodules

Enrollment

500 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with nodules which were sonographically classified as BI-RADS 4 A breast lesion

Exclusion criteria

(i) absence of a pathologic diagnosis; (ii) presence of breast nodules that were too large to compare with normal parenchyma; (iii) patients with radiotherapy and chemotherapy of breast cancer; and (iv) skin disorders.

Trial contacts and locations

1

Loading...

Central trial contact

zimei Lin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems